mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |